← Russell 3000 cross-section

ASPI ASP Isotopes Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-14, not restated
Materials

Scale

Market cap
$617m
Revenue TTM
$31m
Net income TTM
$-117m
Free cash flow
$-84m
Composite score
42.6
Sector rank
#2295

Valuation

P / E
EV / EBITDA
EV / sales
11.9
FCF yield
-13.54%
Earnings yield vs 10-yr
-23.74pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-380.3%
EBITDA margin
-303.3%
ROE
-44.3%
ROIC
-658.1%
Revenue growth
573.4%

Insider activity, last 90 days

Net open-market
$-3.63m
Buyers
0
Sellers
6

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Pursuant to the terms of the agreement, we acquired 100% of the issued and outstanding membership interests for total purchase consideration of $2.5 million of which $2.0 million was paid up front in cash and the remaining $0.5 million was deferred through the issuance of notes payable that are to be repaid by June 30, 2026. Effective with the acquisition of 100% of Renergen in the first quarter of 2026, we started recognizing revenue from the sale of LNG. …ASP Isotopes Inc., 10-Q, period ended 2026-06-30, filed 2026-08-14

Read the full passage →